Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ANGO +6.4%, CALM +4.6%, SMPL +4.2%, AIR +4.1%, KRUS +3.5%, HALO +3.5%, BFLY +3.2% (guidance), GTY +3%, KMDA +2.8% (guidance), MSM +1.2%
Other news:
- SANA +242.4% (Clinical Results from Type 1 Diabetes Study)
- SLDB +19.4% (FDA clears its IND application for SGT-212)
- SGHT +4.8% (announces study for standalone OMNI Surgical System)
- CART +4.5% (to join S&P MidCap 400)
- EMX +3.5% (executes agreement to sell four projects in western USA to Pacific Ridge Exploration)
- VRDN +3.3% (announces the company's key priorities and catalysts for 2025)
- NVO +2.8% (Novo Nordisk A/S and Valo Health expand collaboration to discover and develop novel treatments for cardiometabolic diseases)
- MUR +2.6% (has drilled an oil discovery at Hai Su Vang-1X)
- KBR +2.4% (announces segment reporting updates and executive appointments; reiterates 2027 financial targets)
- BSX +1.8% (agrees to acquire Bolt Medical)
- ENOV +1.7% (to move to S&P SmallCap 600 from S&P MidCap 400)
- PAA +1.5% (Plains All American announces three acquisitions and distribution increase)
- ERJ +1.4% (delivers 75 aircraft in 4Q)
- CGEN +1.3% (Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors)
- PAGP +1.2% (Plains All American announces three acquisitions and distribution increase)